D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Medicine D-index 74 Citations 24,788 649 World Ranking 12807 National Ranking 390

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Surgery

Morgan Rouprêt mostly deals with Urology, Surgery, Bladder cancer, Cancer and Internal medicine. Morgan Rouprêt has included themes like Carcinoma in situ, Carcinoma, Upper urinary tract and Retrospective cohort study in his Urology study. His studies in Surgery integrate themes in fields like Renal cell carcinoma, Nephrectomy and Kidney disease.

His Bladder cancer study combines topics from a wide range of disciplines, such as Renal pelvis, Urinary system and Cystoscopy. As a member of one scientific family, Morgan Rouprêt mostly works in the field of Cancer, focusing on Pathology and, on occasion, Cancer research and DNA methylation. His Internal medicine study combines topics in areas such as Gynecology and Oncology.

His most cited work include:

  • EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. (1390 citations)
  • EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013 (845 citations)
  • European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update (670 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Internal medicine, Urology, Surgery, Oncology and Bladder cancer. His work in Prostate cancer, Nephrology, Cancer, Carcinoma and Retrospective cohort study is related to Internal medicine. His study in Urology is interdisciplinary in nature, drawing from both Stage, Upper tract, Urothelial carcinoma and Upper urinary tract.

His Surgery research is multidisciplinary, relying on both Urinary system, Renal cell carcinoma and Nephrectomy. His Oncology research is multidisciplinary, relying on both Proportional hazards model and Cohort. His Bladder cancer research includes themes of Carcinoma in situ, Urinary bladder, Disease and Chemotherapy.

He most often published in these fields:

  • Internal medicine (30.76%)
  • Urology (27.42%)
  • Surgery (22.24%)

What were the highlights of his more recent work (between 2018-2021)?

  • Bladder cancer (19.59%)
  • Internal medicine (30.76%)
  • Urology (27.42%)

In recent papers he was focusing on the following fields of study:

Bladder cancer, Internal medicine, Urology, Oncology and Cystectomy are his primary areas of study. His Bladder cancer research is multidisciplinary, incorporating elements of Carcinoma in situ, Clinical endpoint, Disease, Proportional hazards model and Concomitant. His Urology study combines topics in areas such as Cancer, Pathological, Confidence interval, Upper tract and Stage.

His studies examine the connections between Upper tract and genetics, as well as such issues in Logistic regression, with regards to Surgery, Area under the curve and Urothelial carcinoma. Morgan Rouprêt has researched Oncology in several fields, including Systematic review and Immunotherapy. Morgan Rouprêt interconnects Perioperative, Chemotherapy and General surgery in the investigation of issues within Cystectomy.

Between 2018 and 2021, his most popular works were:

  • European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update. (304 citations)
  • European Association of Urology Guidelines Office Rapid Reaction Group: An Organisation-wide Collaborative Effort to Adapt the European Association of Urology Guidelines Recommendations to the Coronavirus Disease 2019 Era. (83 citations)
  • EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) (50 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Surgery

Morgan Rouprêt mainly investigates Bladder cancer, Urology, Cystectomy, Internal medicine and Surgery. His work carried out in the field of Bladder cancer brings together such families of science as Disease and Intensive care medicine. His Urology research incorporates themes from Carcinoma in situ, Cancer, Pathological, Hazard ratio and Stage.

His biological study spans a wide range of topics, including Perioperative, Radiation therapy, Chemotherapy and Propensity score matching. His study in Internal medicine is interdisciplinary in nature, drawing from both Oncology and 2019-20 coronavirus outbreak. His Surgery research includes elements of Prostatectomy and Urinary diversion.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016.

Marko Babjuk;Andreas Böhle;Maximilian Burger;Otakar Capoun.
European Urology (2017)

1445 Citations

EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013

Marko Babjuk;Maximilian Burger;Richard Zigeuner;Shahrokh F. Shariat.
European Urology (2013)

1320 Citations

EAU Guidelines on Non-Muscle-Invasive Urothelial Carcinoma of the Bladder, the 2011 Update

M. Babjuk;W. Oosterlinck;R. Sylvester;E. Kaasinen.
European Urology (2011)

918 Citations

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update

Morgan Rouprêt;Marko Babjuk;Eva Compérat;Richard Zigeuner.
European Urology (2015)

670 Citations

European guidelines on upper tract urothelial carcinomas: 2013 update.

Morgan Rouprêt;Marko Babjuk;Eva Compérat;Richard Zigeuner.
European Urology (2013)

496 Citations

European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update.

M. Rouprêt;R. Zigeuner;J. Palou;A. Boehle.
European Urology (2011)

489 Citations

Reporting and Grading of Complications After Urologic Surgical Procedures: An ad hoc EAU Guidelines Panel Assessment and Recommendations

D. Mitropoulos;W. Artibani;M. Graefen;M. Remzi.
European Urology (2012)

401 Citations

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.

Marko Babjuk;Marko Babjuk;Maximilian Burger;Eva M. Compérat;Paolo Gontero.
European Urology (2019)

389 Citations

Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.

Giovanni Lughezzani;Maximilian Burger;Vitaly Margulis;Surena F. Matin.
European Urology (2012)

321 Citations

Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.

Karim Bensalah;Allan J. Pantuck;Nathalie Rioux-Leclercq;Rodolphe Thuret.
European Urology (2008)

283 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Morgan Rouprêt

Shahrokh F. Shariat

Shahrokh F. Shariat

Medical University of Vienna

Publications: 378

Francesco Montorsi

Francesco Montorsi

Vita-Salute San Raffaele University

Publications: 129

Yair Lotan

Yair Lotan

The University of Texas Southwestern Medical Center

Publications: 121

Alberto Briganti

Alberto Briganti

Vita-Salute San Raffaele University

Publications: 102

Pierre I. Karakiewicz

Pierre I. Karakiewicz

University of Montreal

Publications: 102

Ashish M. Kamat

Ashish M. Kamat

The University of Texas MD Anderson Cancer Center

Publications: 83

James W.F. Catto

James W.F. Catto

University of Sheffield

Publications: 67

Jay D. Raman

Jay D. Raman

Penn State Milton S. Hershey Medical Center

Publications: 65

Liang Cheng

Liang Cheng

Indiana University

Publications: 63

Arnulf Stenzl

Arnulf Stenzl

University of Tübingen

Publications: 61

J. Alfred Witjes

J. Alfred Witjes

Radboud University Nijmegen

Publications: 60

Riccardo Autorino

Riccardo Autorino

Virginia Commonwealth University

Publications: 56

Giacomo Novara

Giacomo Novara

University of Padua

Publications: 56

Arndt Hartmann

Arndt Hartmann

University of Erlangen-Nuremberg

Publications: 55

Antonio Lopez-Beltran

Antonio Lopez-Beltran

University of Córdoba

Publications: 51

Wassim Kassouf

Wassim Kassouf

McGill University

Publications: 51

Trending Scientists

Jun Sun

Jun Sun

Jiangnan University

Armin Mosandl

Armin Mosandl

Goethe University Frankfurt

Lester Andrews

Lester Andrews

University of Virginia

Anh V. Nguyen

Anh V. Nguyen

University of Queensland

James B. Adams

James B. Adams

Arizona State University

A.H.W. Ngan

A.H.W. Ngan

University of Hong Kong

Heiko U. Wittmer

Heiko U. Wittmer

Victoria University of Wellington

Mark Rees

Mark Rees

University of Sheffield

Yoshiyuki Mizushina

Yoshiyuki Mizushina

Shinshu University

Toshiyoshi Fujiwara

Toshiyoshi Fujiwara

Okayama University

Kay-Christian Emeis

Kay-Christian Emeis

Universität Hamburg

Chaoyang Wu

Chaoyang Wu

Chinese Academy of Sciences

Sergio Abrignani

Sergio Abrignani

University of Milan

Linda E. Carlson

Linda E. Carlson

University of Calgary

Pierre Duvillard

Pierre Duvillard

Institut Gustave Roussy

Alexey Vikhlinin

Alexey Vikhlinin

Harvard University

Something went wrong. Please try again later.